Intera’s portfolio consists of Intera 3000 Hepatic Artery Infusion Pump, which is used to administer chemotherapy in liver ...

Intera makes a pump and a chemotherapy drug to treat liver tumors. Boston Scientific sees the purchase as a way to provide ...

Boston Scientific has signed a deal to acquire the maker of a chemotherapy infusion pump aimed at treating certain inoperable ...

Boston Scientific (NYSE:BSX) has agreed to acquire medical device maker Intera Oncology for an undisclosed amount, with the ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Intera Oncology, a privately held medical device ...

Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed ...

Boston Scientific Corp. (BSX) announced Monday it has entered into a definitive agreement to acquire Intera Oncology Inc., a ...

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Intera ...

“(She) knew that (hepatic artery infusion) technology actually is very useful for people who are in exactly my position,” Packard says. “Basically, people who have colorectal cancer that ...

The biopsy confirmed that Packard had “adenocarcinoma, which is the most common form of colon cancer,” and a CT scan discovered that the cancer had spread to his liver, making his diagnosis Stage 4 or ...

This is supported by both its intellectual property and the Symplicity Spyral catheter design, which enables access and treatment of the common hepatic artery – a vascular target rich with sympa ...

Also in the press release, Medtronic stated that it intends to investigate multiorgan—hepatic artery and renal artery—denervation with the Symplicity Spyral catheter in the planned SPYRAL GEMINI ...